Kronos Bio Inc (NASDAQ:KRON) price on Friday, March 21, fall -1.07% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.87.
A look at the stock’s price movement, the close in the last trading session was $0.88, moving within a range at $0.87 and $0.93. The beta value (5-Year monthly) was 1.796. Turning to its 52-week performance, $1.60 and $0.69 were the 52-week high and 52-week low respectively. Overall, KRON moved -14.65% over the past month.
Kronos Bio Inc’s market cap currently stands at around $53.08 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Nov-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that KRON is a 100% Sell. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend KRON as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
KRON’s current price about -7.33% and -10.74% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 32.34, while 7-day volatility ratio is 6.89% and 5.82% in the 30-day chart. Further, Kronos Bio Inc (KRON) has a beta value of 1.77, and an average true range (ATR) of 0.05. Analysts have given the company’s stock an average 52-week price target of $1, forecast between a low of $1 and high of $1. Looking at the price targets, the low is -14.94% off current price level while to achieve the yearly target high, price needs to move -14.94%. Nonetheless, investors will most likely welcome a -14.94% jump to $1 which is the analysts’ median price.
If we refocus on Kronos Bio Inc (NASDAQ:KRON), historical trading data shows that trading volumes averaged 0.16 over the past 10 days and 232.42K over the past 3 months. The company’s latest data on shares outstanding shows there are 60.46 million shares.
The 35.66% of Kronos Bio Inc’s shares are in the hands of company insiders while institutional holders own 23.80% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.86 million on 2025-02-28, giving us a short ratio of 4.59. The data shows that as of 2025-02-28 short interest in Kronos Bio Inc (KRON) stood at 188.0 of shares outstanding, with shares short falling to 0.94 million registered in 2025-01-31. Current price change has pushed the stock -8.36% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the KRON stock continues to rise going into the next quarter.
